Stockreport

Day One Biopharmaceuticals: Mersana Acquisition Ignites March Towards Unmet Need [Seeking Alpha]

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana
PDF DAWN announces acquisition of Mersana Therapeutics, gaining access to Emi-Le, a promising B7-H4-targeted ADC for solid tumors with unmet medical needs. The merger off [Read more]